A detailed history of Clarity Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Clarity Asset Management, Inc. holds 244 shares of ABBV stock, worth $43,434. This represents 0.03% of its overall portfolio holdings.

Number of Shares
244
Previous 244 -0.0%
Holding current value
$43,434
Previous $41.8 Million 15.12%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$154.79 - $180.76 $2,631 - $3,072
17 Added 7.49%
244 $41.8 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $7,191 - $8,194
-45 Reduced 16.54%
227 $41.4 Million
Q4 2023

Feb 15, 2024

BUY
$137.6 - $154.97 $37,427 - $42,151
272 New
272 $42.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clarity Asset Management, Inc. Portfolio

Follow Clarity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clarity Asset Management, Inc. with notifications on news.